Pregnant women taking efavirenz-based antiretroviral therapy had significantly better virologic outcomes at the time of delivery compared to those taking lopinavir/ritonavir in a randomised study in rural Uganda, Dr Deborah Cohan, reporting on behalf of the PROMOTE study team, told attendees at the 21st Conference on Retroviruses and Opportunistic ... (more)
http://ift.tt/1erxjk6
http://ift.tt/1erxjk6
No comments:
Post a Comment